Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children
Condition: This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy.Intervention: Drug: TenofovirSponsors: The HIV Netherlands Australia Thailand Research Collaboration; Commission of higher education (CHE), Ministry of Education, Thailand; National Health Security Office, ThailandCompleted - verified March 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Children | Education | Highly Active Antiretroviral Therapy | Research | Study | Universities & Medical Training